{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:01:51Z","timestamp":1792065711816,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":1862,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jtcvs.2011.01.034","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T17:11:59Z","timestamp":1299517919000},"page":"1488-1495","source":"Crossref","is-referenced-by-count":22,"title":["Cardiopulmonary bypass in malignant hyperthermia susceptible patients: A systematic review of published cases"],"prefix":"10.1016","volume":"141","author":[{"given":"Thomas","family":"Metterlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kranke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assad","family":"Haneya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kranke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2011.01.034_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00101-002-0314-9","article-title":"[Malignant hyperthermia. General, clinical and experimental aspects]","volume":"51","author":"Steinfath","year":"2002","journal-title":"Anaesthesist"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1213\/01.ANE.0000068644.31333.BD","article-title":"Is desflurane a \u201cweak\u201d trigger of malignant hyperthermia?","volume":"97","author":"Wappler","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/bja\/85.1.118","article-title":"Malignant hyperthermia: advances in clinical management and diagnosis","volume":"85","author":"Hopkins","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","article-title":"Anaesthetic deaths in a family","volume":"34","author":"Denborough","year":"1962","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib6","first-page":"238243","article-title":"[Regional distribution of predisposition to malignant hyperthermia in Germany: rate in 1997]","volume":"33","author":"Hartung","year":"1998","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1213\/ane.0b013e3181ac1548","article-title":"Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005","volume":"109","author":"Brady","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jmg.30.2.89","article-title":"The genetics of malignant hyperthermia","volume":"30","author":"Ball","year":"1993","journal-title":"J Med Genet"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00003643-200110000-00002","article-title":"Malignant hyperthermia","volume":"18","author":"Wappler","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-2007-1000613","article-title":"[Malignant hyperthermia today]","volume":"26","author":"Roewer","year":"1991","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00101-003-0461-7","article-title":"[Dantrolene. Pharmacological and therapeutic aspects]","volume":"52","author":"Gerbershagen","year":"2003","journal-title":"Anaesthesist"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib14","first-page":"803","article-title":"Prior hypothermia attenuates malignant hyperthermia in susceptible swine","volume":"82","author":"Iaizzo","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJM197405162902006","article-title":"Cardiopulmonary bypass in the treatment of malignant hyperthermia","volume":"290","author":"Ryan","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/ane.0b013e3181a9d8d9","article-title":"The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia","volume":"109","author":"Capacchione","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib17","doi-asserted-by":"crossref","unstructured":"Kranke P. Systematic reviews. Eur J Anaesthesiol. 2010;27:763-72.","DOI":"10.1097\/EJA.0b013e32833a560a"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF03007948","article-title":"Management of a malignant hyperthermia patient during cardiopulmonary bypass","volume":"29","author":"Byrick","year":"1982","journal-title":"Can Anaesth Soc J"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib19","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/BF03010981","article-title":"Development of malignant hyperthermia obscured by cardiopulmonary bypass","volume":"33","author":"MacGillivray","year":"1986","journal-title":"Can Anaesth Soc J"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0888-6296(87)97044-X","article-title":"Cardiopulmonary bypass interference with dantrolene prophylaxis of malignant hyperthermia","volume":"1","author":"Larach","year":"1987","journal-title":"J Cardiothorac Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib21","first-page":"209","article-title":"Malignant hyperthermia: a dilemma for the cardiac surgeon","volume":"30","author":"Landymore","year":"1987","journal-title":"Can J Surg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/j.1365-2044.1987.tb05203.x","article-title":"Propofol infusion for coronary artery bypass surgery in a patient with suspected malignant hyperpyrexia","volume":"42","author":"Richardson","year":"1987","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/0310057X8801600416","article-title":"Propofol during cardiopulmonary bypass in a patient susceptible to malignant hyperpyrexia","volume":"16","author":"Marks","year":"1988","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0888-6296(90)90049-L","article-title":"Case conference 3\u20141990. Two patients develop some signs and symptoms of malignant hyperthermia during cardiac surgery with cardiopulmonary bypass\u2014is it the real thing?","volume":"4","author":"Kleinman","year":"1990","journal-title":"J Cardiothorac Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/1053-0770(91)90330-V","article-title":"Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass","volume":"5","author":"Comunale","year":"1991","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03008693","article-title":"Hyperthermia after cardiopulmonary bypass in a child","volume":"39","author":"Mongan","year":"1992","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/1053-0770(92)90183-8","article-title":"Heart transplantation in a patient with central core disease","volume":"6","author":"Hachenberg","year":"1992","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0003-4975(92)90403-Q","article-title":"Development of malignant hyperthermia during mitral valve replacement","volume":"53","author":"Quinn","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib29","first-page":"229","article-title":"The safety of dantrolene in a patient with a severe cardiomyopathy requiring a heart transplant","volume":"85","author":"Koehntop","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/BF03015452","article-title":"Hyperthermia after cardiac surgery","volume":"44","author":"Abe","year":"1997","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03010893","article-title":"Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management","volume":"36","author":"Allen","year":"1989","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib32","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1053\/jcan.2000.9444","article-title":"Development of malignant hyperthermia during cardiopulmonary bypass","volume":"14","author":"Lindholm","year":"2000","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000542-200102000-00029","article-title":"Rhabdomyolysis following cardiopulmonary bypass and treatment with enoximone in a patient susceptible to malignant hyperthermia","volume":"94","author":"Riess","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/bja\/aeg262","article-title":"Anaesthetic management of coronary artery bypass grafting in a patient with central core disease and susceptibility to malignant hyperthermia on statin therapy","volume":"91","author":"Johi","year":"2003","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1399-6576.2003.00043.x","article-title":"Diagnosis of malignant hyperthermia susceptibility during CABG surgery","volume":"47","author":"Girard","year":"2003","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1053-0770(03)00208-8","article-title":"Development of malignant hyperthermia post-cardiopulmonary bypass during surgery for mitral valve replacement","volume":"17","author":"Pandya","year":"2003","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.0001-5172.2004.00451.x","article-title":"Sevoflurane-induced malignant hyperthermia during cardiopulmonary bypass and moderate hypothermia","volume":"48","author":"Jonassen","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1213\/01.ane.0000189596.70694.36","article-title":"Malignant hyperthermia following systemic rewarming after hypothermic cardiopulmonary bypass","volume":"102","author":"Lichtman","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1213\/01.ane.0000249792.37338.cc","article-title":"Can we prevent malignant hyperthermia after hypothermic cardiopulmonary bypass in a malignant hyperthermia-susceptible patient?","volume":"104","author":"Siddik-Sayyid","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.jvca.2007.11.011","article-title":"Malignant hyperthermia and cardiac surgery","volume":"23","author":"Aeschlimann","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.athoracsur.2009.07.088","article-title":"Delayed malignant hyperthermia after routine coronary artery bypass","volume":"89","author":"Firstenberg","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00001503-199906000-00018","article-title":"Malignant hyperthermia: advances in diagnostics and management","volume":"12","author":"Adnet","year":"1999","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib43","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/00000542-199906000-00031","article-title":"4-chloro-m-cresol is a trigger of malignant hyperthermia in susceptible swine","volume":"90","author":"Wappler","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib44","first-page":"483","article-title":"DGAInfo Empfehlung zur Therapie der malignen Hyperthermie","volume":"9","year":"2008","journal-title":"An\u00e4sth Intensivmed"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1213\/00000539-199407000-00027","article-title":"Response to succinylcholine in porcine malignant hyperthermia","volume":"79","author":"Iaizzo","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/ALN.0b013e31818958e5","article-title":"Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry","volume":"109","author":"Litman","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/1053-0770(91)90330-V","article-title":"Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass","volume":"5","author":"Comunale","year":"1991","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1213\/00000539-198405000-00001","article-title":"Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine","volume":"63","author":"Saltzman","year":"1984","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(76)90120-5","article-title":"The effects of dantrolene sodium on cardiac and skeletal muscle in rats","volume":"39","author":"Meyler","year":"1976","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s001010050186","article-title":"Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia [In German]","volume":"44","author":"Wappler","year":"1995","journal-title":"Anaesthesist"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib52","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1212\/WNL.44.12.2393","article-title":"Gasoline vapors induce severe rhabdomyolysis","volume":"44","author":"Anetseder","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","article-title":"Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis","volume":"94","author":"Wappler","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1017\/S0265021505000475","article-title":"Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine","volume":"22","author":"Fiege","year":"2005","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib55","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jtcvs.2007.10.088","article-title":"Structure and function relationships of the helical ventricular myocardial band","volume":"136","author":"Buckberg","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib56","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1213\/01.ANE.0000160534.23519.1B","article-title":"Cumulative and bolus in vitro contracture testing with 4-chloro-3-ethylphenol in malignant hyperthermia positive and negative human skeletal muscles","volume":"101","author":"Gerbershagen","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib57","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00003643-200307000-00003","article-title":"Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility","volume":"20","author":"Wappler","year":"2003","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00000542-198402000-00017","article-title":"Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia","volume":"60","author":"Ruhland","year":"1984","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib59","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1213\/00000539-199804000-00048","article-title":"Prophylactic use of dantrolene in a patient with central core disease","volume":"86","author":"Michalek-Sauberer","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2011.01.034_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(03)01816-8","article-title":"Dantrolene: effects on abnormal intracellular Ca(2+) handling and inotropy in postinfarcted rat myocardium","volume":"471","author":"Min","year":"2003","journal-title":"Eur J Pharmacol"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522311000997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522311000997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T23:57:41Z","timestamp":1560038261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522311000997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0022522311000997"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2011.01.034","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}